KR102226434B1 - A mixed vegetable powder for promoting intestinal motility and a powdery food composition for improving intestinal health containing it as an active ingredient - Google Patents
A mixed vegetable powder for promoting intestinal motility and a powdery food composition for improving intestinal health containing it as an active ingredient Download PDFInfo
- Publication number
- KR102226434B1 KR102226434B1 KR1020190038946A KR20190038946A KR102226434B1 KR 102226434 B1 KR102226434 B1 KR 102226434B1 KR 1020190038946 A KR1020190038946 A KR 1020190038946A KR 20190038946 A KR20190038946 A KR 20190038946A KR 102226434 B1 KR102226434 B1 KR 102226434B1
- Authority
- KR
- South Korea
- Prior art keywords
- powder
- weight
- vinegar
- mixed vegetable
- spinach
- Prior art date
Links
- 239000000843 powder Substances 0.000 title claims abstract description 176
- 235000013311 vegetables Nutrition 0.000 title claims abstract description 61
- 235000013305 food Nutrition 0.000 title claims description 49
- 230000007413 intestinal health Effects 0.000 title claims description 47
- 239000000203 mixture Substances 0.000 title claims description 34
- 239000004480 active ingredient Substances 0.000 title claims description 13
- 230000001737 promoting effect Effects 0.000 title description 15
- 230000008991 intestinal motility Effects 0.000 title description 7
- 235000021419 vinegar Nutrition 0.000 claims abstract description 36
- 239000000052 vinegar Substances 0.000 claims abstract description 34
- 240000002853 Nelumbo nucifera Species 0.000 claims abstract description 26
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims abstract description 26
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 claims abstract description 25
- 240000007124 Brassica oleracea Species 0.000 claims abstract description 24
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 claims abstract description 24
- 235000012905 Brassica oleracea var viridis Nutrition 0.000 claims abstract description 24
- 235000009337 Spinacia oleracea Nutrition 0.000 claims abstract description 24
- 238000001035 drying Methods 0.000 claims abstract description 12
- 244000300264 Spinacia oleracea Species 0.000 claims abstract description 8
- 238000010298 pulverizing process Methods 0.000 claims abstract description 5
- 244000088415 Raphanus sativus Species 0.000 claims abstract 7
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 40
- 241000894006 Bacteria Species 0.000 claims description 23
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 21
- 239000004310 lactic acid Substances 0.000 claims description 20
- 235000014655 lactic acid Nutrition 0.000 claims description 20
- 235000013618 yogurt Nutrition 0.000 claims description 16
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 14
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 14
- 239000000796 flavoring agent Substances 0.000 claims description 12
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 12
- 235000019634 flavors Nutrition 0.000 claims description 9
- 239000011812 mixed powder Substances 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 9
- 108090000790 Enzymes Proteins 0.000 claims description 8
- 102000004190 Enzymes Human genes 0.000 claims description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 8
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 8
- 239000008103 glucose Substances 0.000 claims description 8
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 8
- 239000000811 xylitol Substances 0.000 claims description 8
- 235000010447 xylitol Nutrition 0.000 claims description 8
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 8
- 229960002675 xylitol Drugs 0.000 claims description 8
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 7
- 235000016623 Fragaria vesca Nutrition 0.000 claims description 7
- 235000011363 Fragaria x ananassa Nutrition 0.000 claims description 7
- 229930003268 Vitamin C Natural products 0.000 claims description 7
- 239000001905 cichorium intybus l. root extract Substances 0.000 claims description 7
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims description 7
- 229940107187 fructooligosaccharide Drugs 0.000 claims description 7
- 239000000377 silicon dioxide Substances 0.000 claims description 7
- 235000012239 silicon dioxide Nutrition 0.000 claims description 7
- 235000019154 vitamin C Nutrition 0.000 claims description 7
- 239000011718 vitamin C Substances 0.000 claims description 7
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 claims description 6
- 240000009088 Fragaria x ananassa Species 0.000 claims description 6
- 244000228451 Stevia rebaudiana Species 0.000 claims description 6
- 239000000905 isomalt Substances 0.000 claims description 6
- 235000010439 isomalt Nutrition 0.000 claims description 6
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 claims description 6
- 235000019359 magnesium stearate Nutrition 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 claims description 6
- 229920002472 Starch Polymers 0.000 claims description 3
- 235000019698 starch Nutrition 0.000 claims description 3
- 239000008107 starch Substances 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 9
- 241000220286 Sedum Species 0.000 abstract description 4
- XZIDTOHMJBOSOX-UHFFFAOYSA-N 2,3,6-TBA Chemical compound OC(=O)C1=C(Cl)C=CC(Cl)=C1Cl XZIDTOHMJBOSOX-UHFFFAOYSA-N 0.000 abstract description 3
- 230000000694 effects Effects 0.000 description 35
- 206010010774 Constipation Diseases 0.000 description 28
- 239000003795 chemical substances by application Substances 0.000 description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 22
- 241000220259 Raphanus Species 0.000 description 18
- 230000001939 inductive effect Effects 0.000 description 18
- 241000219315 Spinacia Species 0.000 description 16
- 239000012153 distilled water Substances 0.000 description 16
- 239000000126 substance Substances 0.000 description 15
- 230000003871 intestinal function Effects 0.000 description 14
- 210000002429 large intestine Anatomy 0.000 description 14
- 238000012360 testing method Methods 0.000 description 14
- 230000000968 intestinal effect Effects 0.000 description 11
- 235000019640 taste Nutrition 0.000 description 11
- 210000000936 intestine Anatomy 0.000 description 10
- 241000700159 Rattus Species 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 9
- 230000002550 fecal effect Effects 0.000 description 9
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 8
- 210000003608 fece Anatomy 0.000 description 6
- 239000000835 fiber Substances 0.000 description 6
- 230000036541 health Effects 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 235000019629 palatability Nutrition 0.000 description 5
- 241000186606 Lactobacillus gasseri Species 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 150000001720 carbohydrates Chemical class 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 235000013325 dietary fiber Nutrition 0.000 description 4
- 210000002249 digestive system Anatomy 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 210000001035 gastrointestinal tract Anatomy 0.000 description 4
- 229910052742 iron Inorganic materials 0.000 description 4
- 230000005012 migration Effects 0.000 description 4
- 238000013508 migration Methods 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000186016 Bifidobacterium bifidum Species 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 108091005960 Citrine Proteins 0.000 description 3
- 241000186660 Lactobacillus Species 0.000 description 3
- 240000002605 Lactobacillus helveticus Species 0.000 description 3
- 235000013967 Lactobacillus helveticus Nutrition 0.000 description 3
- 241000186869 Lactobacillus salivarius Species 0.000 description 3
- 241000194020 Streptococcus thermophilus Species 0.000 description 3
- 208000007502 anemia Diseases 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 229940002008 bifidobacterium bifidum Drugs 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 235000001465 calcium Nutrition 0.000 description 3
- 239000011035 citrine Substances 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 230000013872 defecation Effects 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 229940039696 lactobacillus Drugs 0.000 description 3
- 229940054346 lactobacillus helveticus Drugs 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 230000035807 sensation Effects 0.000 description 3
- 235000019615 sensations Nutrition 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 241001134770 Bifidobacterium animalis Species 0.000 description 2
- 241000186012 Bifidobacterium breve Species 0.000 description 2
- 241001608472 Bifidobacterium longum Species 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- 240000001046 Lactobacillus acidophilus Species 0.000 description 2
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 2
- 244000199885 Lactobacillus bulgaricus Species 0.000 description 2
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 description 2
- 241000186840 Lactobacillus fermentum Species 0.000 description 2
- 241000186605 Lactobacillus paracasei Species 0.000 description 2
- 240000006024 Lactobacillus plantarum Species 0.000 description 2
- 235000013965 Lactobacillus plantarum Nutrition 0.000 description 2
- 241000186604 Lactobacillus reuteri Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 244000057717 Streptococcus lactis Species 0.000 description 2
- 235000014897 Streptococcus lactis Nutrition 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 229940118852 bifidobacterium animalis Drugs 0.000 description 2
- 229940009291 bifidobacterium longum Drugs 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 2
- 229940004208 lactobacillus bulgaricus Drugs 0.000 description 2
- 229940012969 lactobacillus fermentum Drugs 0.000 description 2
- 229940072205 lactobacillus plantarum Drugs 0.000 description 2
- 229940001882 lactobacillus reuteri Drugs 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- GOZDTZWAMGHLDY-UHFFFAOYSA-L sodium picosulfate Chemical compound [Na+].[Na+].C1=CC(OS(=O)(=O)[O-])=CC=C1C(C=1N=CC=CC=1)C1=CC=C(OS([O-])(=O)=O)C=C1 GOZDTZWAMGHLDY-UHFFFAOYSA-L 0.000 description 2
- 229960005077 sodium picosulfate Drugs 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000019156 vitamin B Nutrition 0.000 description 2
- 239000011720 vitamin B Substances 0.000 description 2
- IPVYMXZYXFFDGW-UHFFFAOYSA-N 1-methylpiperidin-4-ol;hydrochloride Chemical compound Cl.CN1CCC(O)CC1 IPVYMXZYXFFDGW-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241001449342 Chlorocrambe hastata Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- 244000307700 Fragaria vesca Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 244000199866 Lactobacillus casei Species 0.000 description 1
- 235000013958 Lactobacillus casei Nutrition 0.000 description 1
- 241000218588 Lactobacillus rhamnosus Species 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- AUYYCJSJGJYCDS-LBPRGKRZSA-N Thyrolar Chemical class IC1=CC(C[C@H](N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-LBPRGKRZSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 208000020560 abdominal swelling Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 229940124382 agent for constipation Drugs 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 210000003403 autonomic nervous system Anatomy 0.000 description 1
- 208000024330 bloating Diseases 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000000112 colonic effect Effects 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 235000015140 cultured milk Nutrition 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000002650 habitual effect Effects 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 229940017800 lactobacillus casei Drugs 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- RDOIQAHITMMDAJ-UHFFFAOYSA-N loperamide Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(C(=O)N(C)C)CCN(CC1)CCC1(O)C1=CC=C(Cl)C=C1 RDOIQAHITMMDAJ-UHFFFAOYSA-N 0.000 description 1
- 229960001571 loperamide Drugs 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- 235000012245 magnesium oxide Nutrition 0.000 description 1
- 229960000869 magnesium oxide Drugs 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 239000005495 thyroid hormone Substances 0.000 description 1
- 229940036555 thyroid hormone Drugs 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 235000001366 vegetable intake Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/01—Instant products; Powders; Flakes; Granules
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
- A23P10/22—Agglomeration or granulation with pulverisation of solid particles, e.g. in a free-falling curtain
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/10—Drying, dehydrating
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/31—Mechanical treatment
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
본 발명은 a) 세척된 케일, 신선초, 연근, 시금치, 무 잎 및 삼백초를30~50℃에서 8~15시간 동안 저온 건조 하는 단계; 및 b) 건조된 케일, 신선초, 연근, 시금치, 무 잎 및 삼백초를 각각 믹서로 분쇄하여 50~120 mesh의 케일 분말, 신선초 분말, 연근 분말, 시금치 분말, 무 잎 분말 및 삼백초 분말을 제조하는 단계;를 포함하는 것을 특징으로 하는 장 운동을 촉진하는 혼합야채분말의 제조방법에 관한 것이다.The present invention comprises the steps of: a) drying the washed kale, fresh vinegar, lotus root, spinach, radish leaves, and 300 vinegar at low temperature for 8 to 15 hours at 30 to 50°C; And b) pulverizing the dried kale, sedum serrata, lotus root, spinach, radish leaves, and 300 vinegars with a mixer to prepare 50 to 120 mesh kale powder, sedum vinegar powder, lotus root powder, spinach powder, radish leaf powder, and tribac vinegar powder. It relates to a method for producing a mixed vegetable powder that promotes bowel movement, comprising;
Description
본 발명은 장 운동을 촉진하는 혼합야채분말 및 이를 유효성분으로 함유하는 장 건강 개선용 분말식품 조성물에 관한 것이다.The present invention relates to a mixed vegetable powder that promotes bowel movement and a powdered food composition for improving bowel health containing the same as an active ingredient.
최근에 산업경제가 발달함에 따라 예전에 비해 풍요로운 물질적 혜택을 누리고 있으며, 이로 인해 현대인들이 섭취하는 영양소 또한 과거에 비해 다양하고 과다하게 이루어지고 있는 것이나 서구식 문명의 유입과 신속과 일정한 시간의 틀 내에서 활동하여야 하는 생활 패턴의 변경으로 인하여 밥 등의 주식을 대신하여 조리, 저장, 휴대가 간편한 인스턴트 식품의 애용이 증가되고 있는 실정이다. 상기와 같은 인스턴트 식품의 남용은 단백질, 지방 등의 영양소가 위와 장에서 소화 및 흡수되지 못하고, 소화 및 흡수되지 못한 영양소가 소화기 계통의 마지막에 위치한 대장까지 밀려가 대장 내의 유해균에 의해 부패하면서 대장 내에 황화수소, 암모니아, 페놀, 인돌, 히스타민, 아민 등의 독소가 발생하게 된다. 어린이나 청소년의 경우는 인스턴트의 애용 증가 및 편식으로 인하여, 야채의 섭취가 과거에 비해 현저하게 줄어들었고, 이는 소화기관을 자극하는 식이섬유가 부족해 변비 발생을 초래하였다. 더욱이, 어린이 및 청소년은 책상에 앉아서 대부분의 시간을 할애하고 있기에, 대장질환에 대한 저항력 저하와 지속적인 만성변비에 노출되어 있는 실정이다.With the recent development of the industrial economy, they are enjoying rich material benefits compared to the past, and as a result, the nutrients consumed by modern people are also becoming more diverse and more abundant than in the past. Due to the change in life patterns that must be active in the country, the habitual use of instant foods that are easy to cook, store, and carry in place of stocks such as rice is increasing. The abuse of instant foods as described above is that nutrients such as proteins and fats cannot be digested and absorbed in the stomach and intestines, and nutrients that cannot be digested and absorbed are pushed to the large intestine located at the end of the digestive system and are decayed by harmful bacteria in the Toxins such as hydrogen sulfide, ammonia, phenol, indole, histamine, and amines are generated. In the case of children and adolescents, due to the increased use of instant food and unbalanced diet, consumption of vegetables was significantly reduced compared to the past, which caused constipation due to lack of dietary fiber that stimulates the digestive system. Moreover, since children and adolescents spend most of their time sitting at their desks, they are exposed to decreased resistance to bowel disease and persistent chronic constipation.
또한, 종래에는 대장에 문제가 발생하는 경우, 예를 들어 변비가 발생하면 치료를 위해 치료제를 복용하는데, 이러한 치료는 예방적인 활동이 아니고 대장에 이상이 생긴 후에야 사용하는 문제점이 있다.In addition, conventionally, when a problem occurs in the large intestine, for example, when constipation occurs, a therapeutic agent is taken for treatment, but such treatment is not a prophylactic activity, but it is used only after an abnormality occurs in the large intestine.
소비자들, 특히 어린이들이 용이하게 섭취할 수 있는 장 기능 활성이 증진된 혼합야채분말을 유효성분으로 함유하는 장 건강 개선용 분말식품을 제공하는 것을 목적으로 한다.It is an object of the present invention to provide a powdered food for improving intestinal health, containing as an active ingredient, mixed vegetable powder with enhanced intestinal function activity that consumers, especially children, can easily consume.
본 발명은 장 운동을 촉진하는 혼합분말의 제조방법에 있어서, a) 세척된 케일, 신선초, 연근, 시금치, 무 잎 및 삼백초를 30~50℃에서 8~15시간 동안 저온 건조 하는 단계; 및 b) 건조된 케일, 신선초, 연근, 시금치, 무 잎 및 삼백초를 각각 믹서로 분쇄하여 50~120 mesh의 케일 분말, 신선초 분말, 연근 분말, 시금치 분말, 무 잎 분말 및 삼백초 분말을 제조하는 단계;를 포함하여 제조되는 것을 특징으로 한다.The present invention provides a method for producing a mixed powder that promotes bowel movement, comprising: a) drying the washed kale, fresh vinegar, lotus root, spinach, radish leaves, and 300 vinegar at a low temperature for 8 to 15 hours at 30 to 50°C; And b) pulverizing the dried kale, sedum serrata, lotus root, spinach, radish leaves, and 300 vinegars with a mixer to prepare 50 to 120 mesh kale powder, sedum vinegar powder, lotus root powder, spinach powder, radish leaf powder, and tribac vinegar powder. It characterized in that it is manufactured including;
또한, 본 발명은 장 운동을 촉진하는 혼합야채분말 제조방법에 있어서, 케일 분말 20~40 중량%, 신선초 분말 20~30 중량%, 연근 분말 10~20 중량%, 시금치 분말 10~20 중량%, 무 잎 분말 5~15 중량% 및 삼백초 분말 5~15 중량%를 혼합하는 단계를 포함하여 제조되는 것을 특징으로 한다.In addition, the present invention in the mixed vegetable powder manufacturing method to promote bowel movement,
또한, 본 발명은 상기 기재된 방법에 따라 제조된 장 운동을 촉진하는 혼합야채분말을 제공하는 것을 특징으로 한다.In addition, the present invention is characterized in that it provides a mixed vegetable powder that promotes bowel movement prepared according to the method described above.
또한, 본 발명은 상기 장 운동을 촉진하는 혼합야채분말을 유효성분으로 함유하는 장 건강 개선용 분말식품 조성물을 제공하는 것을 특징으로 한다.In addition, the present invention is characterized in that it provides a powdered food composition for improving intestinal health, containing a mixed vegetable powder that promotes intestinal movement as an active ingredient.
또한, 본 발명의 상기 장 건강 개선용 분말식품 조성물은 정제포도당 30~40 중량%, 요구르트 혼합 분말 12~20 중량%, 이소말트 10~15 중량%, 치커리뿌리추출물 분말 5~15 중량%, 자일리톨 5~10 중량% 유산균혼합분말 3~7 중량%, 프락토올리고당 3~7 중량%, 요구르트향분말 2~4 중량%, 이산화규소 0.5~2 중량%, 스테아린산마그네슘 0.5~2 중량%, 동결건조딸기분말 0.1~1 중량%, 사과농축분말 0.1~1 중량%, 구연산 0.1~1 중량%, 비타민C 0.1~1 중량%, 효소처리스테비아 0.05~0.5 중량%, 혼합야채분말 0.05~0.1 중량%를 유효성분으로 함유하는 것을 특징으로 한다.In addition, the powdered food composition for improving intestinal health of the present invention is purified glucose 30-40% by weight, yogurt mixed powder 12-20% by weight, isomalt 10-15% by weight, chicory root extract powder 5-15% by weight, xylitol 5-10% by weight lactic acid bacteria mixture powder 3-7% by weight, fructooligosaccharide 3-7% by weight, yogurt flavor powder 2-4% by weight, silicon dioxide 0.5-2% by weight, magnesium stearate 0.5-2% by weight, freeze-dried Strawberry powder 0.1-1 wt%, apple concentrated powder 0.1-1 wt%, citric acid 0.1-1 wt%, vitamin C 0.1-1 wt%, enzyme-treated stevia 0.05-0.5 wt%, mixed vegetable powder 0.05-0.1 wt% It is characterized by containing as an active ingredient.
또한, 상기 유산균혼합분말은 유산균 56.4 중량% 및 전분가공품 43.6 중량%로 이루어진 것을 특징으로 한다.In addition, the lactic acid bacteria mixture powder is characterized by consisting of 56.4% by weight of lactic acid bacteria and 43.6% by weight of processed starch.
또한, 상기 유산균은 락토바실러스 플란타럼(Lactobacillus plantarum), 락토코커스 락티스 (Lactococcus lactis), 비피도박테리움 애니멀리스(Bifidobacterium animalis ssp. lactis), 락토바실러스 람노서스(Lactobacillus rhamnosus), 락토바실러스 카세이 (Lactobacillus casei), 비피도박테리움 브레베(Bifidobacterium breve), 비피도박테리움 롤검(Bifidobacterium longum), 락토바실러스 퍼멘텀(Lactobacillus fermentum) , 락토바실러스 루테리(Lactobacillus reuteri), 스트렙토코커스 써모필러스(Streptococcus thermophilus), 락토바실러스 에시도필러스(Lactobacillus acidophilus), 락토바실러스 파라카제이(Lactobacillus paracasei), 락토바실러스 불가리쿠스(Lactobacillus bulgaricus), 락토바실러스 가세리(Lactobacillus gasseri), 락토바실러스 헬베티커스(Lactobacillus helveticus) , 락토바실러스 살리바리우스(Lactobacillus salivarius), 비피도박테리움 비피덤(Bifidobacterium bifidum)으로 이루어진 것을 특징으로 한다.In addition, the lactic acid bacteria are Lactobacillus plantarum, Lactococcus lactis, Bifidobacterium animalis ssp. (Lactobacillus casei), Bifidobacterium breve, Bifidobacterium longum, Lactobacillus fermentum, Lactobacillus reuteri, Streptococcus thermophilus thermophilus), Lactobacillus acidophilus, Lactobacillus paracasei, Lactobacillus bulgaricus, Lactobacillus gasseri, Lactobacillus gasseri, Lactobacillus helveticus ), Lactobacillus salivarius (Lactobacillus salivarius), characterized by consisting of Bifidobacterium bifidum (Bifidobacterium bifidum).
또한, 본 발명은 상기 장 건강 개선용 분말식품 조성물에 추가로 얌빈 분말 0.5~1 중량%를 더 함유하는 것을 특징으로 한다.In addition, the present invention is characterized in that it further contains 0.5 to 1% by weight of yambin powder in addition to the powdered food composition for improving intestinal health.
본 발명은 정장 작용 및 배변촉진에 대한 효과가 있는 혼합야채분말 및 상기 혼합야채분말을 유효성분으로 함유하는 장 기능 개선용 분말식품을 제공할 수 있는 효과가 있다.The present invention has the effect of providing a mixed vegetable powder having an effect on intestinal action and promotion of bowel movements, and a powdered food for improving intestinal function containing the mixed vegetable powder as an active ingredient.
본 발명은 기호성과 식음성을 향상시킬 수 있는 배합비를 제시함으로써, 소비자들, 특히 어린이들이 용이하게 섭취할 수 있는 장 운동을 촉진하는 혼합야채분말을 유효성분으로 함유하는 장 건강 개선용 분말식품을 제공할 수 있는 효과가 있다.The present invention provides a powdered food for improving intestinal health containing as an active ingredient a mixed vegetable powder that promotes bowel movement that can be easily consumed by consumers, especially children, by suggesting a blending ratio that can improve palatability and food and drink. There is an effect it can provide.
도1은 본 발명의 장 운동을 촉진하는 증진된 혼합야채분말의 제조방법을 나타낸 순서도이다.
도2은 시험예1의 결과로서, 대장 내의 잔여 변의 개수와 직경변화를 나타낸 그래프이다.
도3은 시험예2의 결과로서, 대장 내의 잔여 변의 개수와 직경변화를 나타낸 그래프이다.
도4은 시험예2의 결과로서, 장내 분변 이동률을 나타낸 그래프이다.Figure 1 is a flow chart showing the manufacturing method of the improved mixed vegetable powder to promote bowel movement of the present invention.
2 is a graph showing the change in the number and diameter of residual stools in the large intestine as a result of Test Example 1.
3 is a graph showing the change in the number and diameter of the remaining stools in the large intestine as a result of Test Example 2.
4 is a graph showing the fecal movement rate in the intestine as a result of Test Example 2.
본 발명을 충분히 이해하기 위해서 본 발명의 바람직한 실시예를 참조하여 설명한다. 본 발명의 실시예는 여러가지 형태로 변형될 수 있으며, 본 발명의 범위가 아래에서 상세히 설명하는 실시예로 한정되는 것으로 해석되어서는 안된다. 본 실시예는 당업계에서 통상의 지식을 가진 자에게 본 발명을 보다 완전하게 설명하기 위하여 제공되는 것이다.In order to fully understand the present invention, it will be described with reference to preferred embodiments of the present invention. The embodiments of the present invention may be modified in various forms, and the scope of the present invention should not be construed as being limited to the embodiments described in detail below. This embodiment is provided to more completely explain the present invention to those of ordinary skill in the art.
본 발명은 정장 작용 및 배변촉진에 대한 효과가 있는 혼합야채분말 및 상기 혼합야채분말을 유효성분으로 함유하는 장 기능 개선용 분말식품을 제공할 수 있는 효과가 있다.The present invention has the effect of providing a mixed vegetable powder having an effect on intestinal action and promotion of bowel movements, and a powdered food for improving intestinal function containing the mixed vegetable powder as an active ingredient.
도 1은 본 발명의 일실시 예로 장 운동을 촉진하는 혼합야채분말의 제조방법을 나타낸 순서도이다.1 is a flow chart showing a method of manufacturing a mixed vegetable powder to promote bowel movement as an embodiment of the present invention.
상기 도 1을 참조하여 장 운동을 촉진하는 혼합야채분말의 제조방법을 아래와 같이 설명하고자 한다.A method of manufacturing a mixed vegetable powder that promotes bowel movement will be described with reference to FIG. 1 as follows.
본 발명은 장 운동을 촉진하는 혼합야채분말의 제조방법에 있어서, a) 세척된 케일, 신선초, 연근, 시금치, 무 잎 및 삼백초를 30~50℃에서 8~15시간 동안 저온 건조 하는 단계; 및 b) 건조된 케일, 신선초, 연근, 시금치, 무 잎 및 삼백초를 각각 믹서로 분쇄하여 50~120 mesh의 케일 분말, 신선초 분말, 연근 분말, 무 잎 분말 및 삼백초 분말을 제조하는 단계;를 포함하여 제조되는 것을 특징으로 한다.The present invention provides a method for producing a mixed vegetable powder that promotes bowel movement, a) drying the washed kale, fresh vinegar, lotus root, spinach, radish leaves, and 300 vinegar at a low temperature for 8 to 15 hours at 30 to 50°C; And b) pulverizing the dried kale, fresh vinegar, lotus root, spinach, radish leaves, and 300 vinegar with a mixer, respectively, to prepare 50 to 120 mesh kale powder, spear vinegar powder, lotus root powder, radish leaf powder, and 300 vinegar powder; including It characterized in that it is manufactured by.
상기 케일, 신선초, 연근, 시금치, 무 잎 및 삼백초를 30~50℃에서 8~15시간 동안 저온에서 건조하는 것은 장내 배변활동을 촉진시키는 유익한 미생물이나 효소 등이 사멸되지 않게 하기 위해서 이며, 30℃ 미만으로 건조되는 경우에는 건조가 잘 진행되지 않거나 건조시간이 너무 길어지게되어, 시간대비 경제적이지 않고, 50℃를 초과하여 건조되는 경우에는 효소가 변성되어 활성이 저하되기 때문이다. 상기 케일, 신선초, 연근, 시금치, 무 잎 및 삼백초를 8시간 미만으로 건조 시 수분이 완전하게 증발하지 않아 문제가 될 수 있으며, 15시간을 초과하여 건조하는 경우에는 장시간 건조로 장내 유익한 미생물이 사멸하게 되는 문제가 있다.Drying the kale, fresh vinegar, lotus root, spinach, radish leaves, and 300 vinegar at a low temperature for 8 to 15 hours at 30 to 50°C is to prevent the death of beneficial microorganisms or enzymes that promote bowel movements in the intestine, and 30°C. If it is dried to less than that, the drying does not proceed well or the drying time becomes too long, which is not economical compared to the time, and when the drying exceeds 50°C, the enzyme is denatured and the activity is lowered. If the kale, fresh vinegar, lotus root, spinach, radish leaves, and 300 vinegar are dried for less than 8 hours, moisture does not completely evaporate, which can be a problem.If dried for more than 15 hours, beneficial microorganisms in the intestine are killed by drying for a long time. There is a problem to be done.
상기 케일 분말, 신선초 분말, 연근 분말, 무 잎 분말 및 삼백초 분말의 입자가 50메쉬(mesh) 미만일 경우, 섭취시 질감을 저하시키고, 수용액에서 용해성이 저하되어 전체적인 기호성을 저하시키고, 120 메쉬(mesh)를 초과할 경우, 과도하게 미분화된 분말로 인해 섭취시 기침을 유발하는 문제가 있다. 따라서 상기 기재된 메쉬 범위에서 혼합야채분말을 제조하는 것이 적절하다.When the particles of the kale powder, fresh vinegar powder, lotus root powder, radish leaf powder, and 300 mesh powder are less than 50 mesh, the texture is lowered when ingested, solubility in aqueous solution is lowered, thereby lowering the overall palatability, and 120 mesh (mesh ), there is a problem of causing cough when ingested due to excessively micronized powder. Therefore, it is appropriate to prepare a mixed vegetable powder in the above-described mesh range.
또한, 이와 같은 장 운동을 촉진하는 혼합야채분말에 이용되는 각 조성물은 각각에 대하여 케일 분말 20~40 중량%, 신선초 분말 20~30 중량%, 연근 분말 10~20 중량%, 시금치 분말 10~20 중량%, 무 잎 분말 10~20 중량% 및 삼백초 분말 5~15 중량%를 혼합하는 것을 특징으로 한다.In addition, each composition used in the mixed vegetable powder that promotes bowel movement is 20 to 40% by weight of kale powder, 20 to 30% by weight of fresh vinegar powder, 10 to 20% by weight of lotus root powder, and 10 to 20 of spinach powder, respectively. It is characterized in that mixing the weight%, the radish leaf powder 10-20% by weight, and the tribaekcho powder 5-15% by weight.
상기 장 운동을 촉진하는 혼합야채분말에 이용되는 각 조성물의 효능을 살펴보면 다음과 같다.The efficacy of each composition used in the mixed vegetable powder that promotes bowel movement is as follows.
케일은 탄수화물, 단백질, 비타민류, 칼슘, 철, 엽록소 등이 함유되어 있고 항암, 동맥경화, 간장병, 위장, 비만, 신장병, 빈혈 등에 효능이 있다. 상기 장 운동을 촉진하는 혼합야채분말에 이용되는 케일분말이 20 중량% 미만일 경우, 상기 장 운동 활성의 기능을 최대로 발현시키기가 용이하지 못하고, 40 중량%를 초과할 경우에는 가격 상승을 초래시키고, 상대적으로 다른 성분들의 첨가량이 감소되어 야채혼합분말의 장 운동 촉진 효과를 달성하기 어려운 문제가 있다.Kale contains carbohydrates, proteins, vitamins, calcium, iron, and chlorophyll, and is effective in anti-cancer, arteriosclerosis, liver disease, gastrointestinal, obesity, kidney disease, and anemia. When the kale powder used in the mixed vegetable powder that promotes intestinal motility is less than 20% by weight, it is not easy to maximize the function of the intestinal motility activity, and when it exceeds 40% by weight, it causes an increase in price. However, there is a problem in that it is difficult to achieve the effect of promoting intestinal movement of the vegetable mixture powder because the amount of other ingredients is relatively reduced.
신선초는 비타민 B군, 플라보노이드, 루테오닌, 이소쿠엘치트린 등이 주요 함유성분으로서 고혈압, 빈혈, 당뇨, 신경통, 이뇨, 피로 회복의 효능이 있다. 장 운동을 촉진하는 혼합야채분말에 이용되는 신선초 분말이 20 중량% 미만일 경우, 상기 신선초가 가지는 유효소성분의 효과가 미미하여 신선초의 기능성을 기대할 수 없고, 30 중량%를 초과할 경우에는 신선초 특유의 씁쓸함이 느껴져, 혼합야채분말에 대한 전체적인 식미감이 크게 저하될 수 있는 문제가 있다.Sinseoncho contains B vitamins, flavonoids, luteonine, isoquel citrine, etc. as its main ingredients. It is effective in recovering from high blood pressure, anemia, diabetes, neuralgia, diuresis, and fatigue. When the amount of fresh vinegar powder used in the mixed vegetable powder that promotes bowel movement is less than 20% by weight, the effect of the effective ingredients of the spearhead is insignificant, so the functionality of the sprout cannot be expected, and if it exceeds 30% by weight, it is unique to Sseoncho. There is a problem that the bitterness is felt, and the overall taste of the mixed vegetable powder may be greatly reduced.
연근은 주성분이 탄수화물로 식물성 섬유가 풍부한데, 이 식물성 섬유는 장벽을 적당히 자극해 장의 활동을 활발하게 해주므로, 숙변해소 및 변비해소에 효과가 있다. 장 운동을 촉진하는 혼합야채분말에 이용되는 연근 분말이 10 중량% 미만일 경우, 상기 장 기능 활성의 기능을 최대로 발현시키기가 용이하지 못하고, 20 중량%를 초과할 경우에는 연근에 포함된 점성 성분으로 인하여, 물과 함께 섭취 시, 걸쭉하고 진해 흐름성이 나빠진다. 또한, 연근 특유의 아린 맛으로 인하여, 혼합야채분말에 대한 소비자의 기호성을 저감시킬 수 있는 문제가 있다.Lotus root is rich in vegetable fiber as the main component of carbohydrates. This vegetable fiber moderately stimulates the intestinal tract to activate the intestines, so it is effective in relieving sukbyeon and constipation. When the lotus root powder used in the mixed vegetable powder that promotes bowel movement is less than 10% by weight, it is not easy to maximize the function of the intestinal function activity, and when it exceeds 20% by weight, the viscous component contained in the lotus root Because of this, when ingested with water, the thick and thick water flow deteriorates. In addition, due to the unique taste of lotus root, there is a problem in that it is possible to reduce consumer preference for mixed vegetable powder.
시금치는 비타민A가 다량 함유되어 있으며 칼슘과 철분, 요오드 등이 많아서 발육기의 어린이는 물론 임산부에게 좋은 알칼리성 식품으로서 시금치의 철분과 염산은 빈혈예방에 효과가 있으며 사포닌과 질 좋은 섬유는 비만증, 변비에 효과가 있다. 장 운동을 촉진하는 혼합야채분말에 이용되는 시금치 분말이 10 중량% 미만일 경우, 상기 장 기능 활성의 기능을 최대로 발현시키기가 용이하지 못하고, 20 중량%를 초과할 경우에는 시금치에 포함된 요오드의 지나친 섭취로 인하여, 갑상샘 호르몬의 생성이 억제될 수 있고, 함량 초과에 따른 이익이 없어 경제성이 저하될 수 있다.Spinach contains a large amount of vitamin A and contains a lot of calcium, iron and iodine, so it is an alkaline food that is good for pregnant women as well as children in the developing period. Iron and hydrochloric acid in spinach are effective in preventing anemia, and saponin and good fiber are effective for obesity and constipation. It works. When the spinach powder used in the mixed vegetable powder that promotes bowel movement is less than 10% by weight, it is not easy to maximize the function of the intestinal function activity, and when it exceeds 20% by weight, the amount of iodine contained in spinach Due to excessive intake, the production of thyroid hormone may be suppressed, and there is no benefit due to excess content, and thus economic feasibility may be reduced.
무 잎은 카로틴, 비타민B 1, B 2, C, 나이아신, 철, 칼슘이 풍부하게 함유되어 있고 필수 아미노산도 다량 함유되어 있으며 섬유소와 각종 비타민이 풍부해 변비에 좋다 장 운동을 촉진하는 혼합야채분말에 이용되는 무 잎 분말이 5 중량% 미만일 경우, 상기 무 잎이 가지는 유효소성분의 효과가 미미하여 변비개선 및 장 운동에 대한 약리활성을 최대로 발현시키기 어렵고, 15 중량%를 초과할 경우에는 상대적으로 다른 성분들의 첨가량이 감소되어 장 온동 개선에 대한 각 성분 간의 상호 보완적 상승작용을 기대하기 어렵다.Radish leaves are rich in carotene, vitamins B 1,
삼백초는 쿠엘치트린, 이소쿠엘치트린, 플라보노이드 등의 성분이 함유되어 있어 변비에 좋으며 이뇨, 해독, 항균, 소종 등의 작용과 함께 각종 성인병 예방에 좋은 작용이 있으며, 특히 항암작용이 있는 것으로 알려지고 있다. 장 운동을 촉진하는 혼합야채분말에 이용되는 삼백초 분말이 5 중량% 미만일 경우, 상기 장 기능 활성의 기능을 최대로 발현시키기가 용이하지 못하고, 15 중량%를 초과할 경우에는 함량 초과에 따른 이익이 없어 경제성이 저하될 수 있다.Sambaekcho contains components such as quel citrine, iso quel citrine, and flavonoids, so it is good for constipation. Is losing. When the amount of the three baekcho powder used in the mixed vegetable powder that promotes intestinal motility is less than 5% by weight, it is not easy to maximize the function of the intestinal function activity, and when it exceeds 15% by weight, the benefit of excess content is If there is no, economic feasibility may be deteriorated.
한편, 본 발명은 상기 기재된 제조방법에 따라 제조된 혼합 야채 분말을 이용하여 장 건강 개선용 분말식품을 제공 할 수 있는 특징이 있다. 상기 장 건강 개선용 분말식품 야채분말이 첨가된 기존의 제품과는 달리 비린맛이나 역겨운 냄새 등이 느껴지지 않아 섬유질과 다양한 유효성분을 포함하는 야채를 다양한 연령계층이 복용할 수 있는 효과가 있다.On the other hand, the present invention has a feature that can provide a powdered food for improving intestinal health by using the mixed vegetable powder prepared according to the above-described manufacturing method. Unlike conventional products to which the powdered food for improving intestinal health and vegetable powder is added, a fishy taste or a disgusting odor is not felt, so there is an effect that vegetables containing fiber and various active ingredients can be taken by various age groups.
상기 장 건강 개선용 분말식품 조성물은 정제포도당 30~40 중량%, 요구르트 혼합 분말 12~20 중량%, 이소말트 10~15 중량%, 치커리뿌리추출물 분말 5~15 중량%, 자일리톨 5~10 중량% 유산균혼합분말 3~7 중량%, 프락토올리고당 3~7 중량%, 요구르트향분말 2~4 중량%, 이산화규소 0.5~2 중량%, 스테아린산마그네슘 0.5~2 중량%, 동결건조딸기분말 0.1~1 중량%, 사과농축분말 0.1~1 중량%, 구연산 0.1~1 중량%, 비타민C 0.1~1 중량%, 효소처리스테비아 0.05~0.5 중량%, 혼합야채분말 0.05~0.1 중량%를 유효성분으로 함유하는 것을 특징으로 한다.The powdered food composition for improving intestinal health is 30 to 40% by weight of purified glucose, 12 to 20% by weight of yogurt mixed powder, 10 to 15% by weight of isomalt, 5 to 15% by weight of chicory root extract powder, and 5 to 10% by weight of xylitol Lactobacillus mixture powder 3-7% by weight, fructooligosaccharide 3-7% by weight, yogurt flavor powder 2-4% by weight, silicon dioxide 0.5-2% by weight, magnesium stearate 0.5-2% by weight, freeze-dried strawberry powder 0.1-1 Containing weight%, apple concentrated powder 0.1-1% by weight, citric acid 0.1-1% by weight, vitamin C 0.1-1% by weight, enzyme-treated stevia 0.05-0.5% by weight, mixed vegetable powder 0.05-0.1% by weight as active ingredients It is characterized by that.
장 건강 개선용 분말식품에 이용되는 정제 포도당이 30중량% 미만으로 첨가될 경우, 당도와 성형성을 저하시킨다. 이에 따라서, 분말이 달지 않고, 분말끼리 서로 응집되어 부드러운 식감을 저해할 수 있다. 또한, 정제 포도당이 40중량%를 초과하여 첨가될 경우, 분말의 감미가 너무 달고, 과한 당분으로 인하여 고칼로리가 되는 문제가 있다.When the refined glucose used in powdered foods for improving intestinal health is added in an amount of less than 30% by weight, sugar content and moldability are reduced. Accordingly, the powder is not sweet, and the powder is agglomerated with each other, thereby inhibiting the soft texture. In addition, when the purified glucose is added in excess of 40% by weight, the sweetness of the powder is too sweet, and there is a problem that the powder becomes high calorie due to excessive sugar content.
장 건강 개선용 분말식품에 이용되는 요구르트 혼합 분말은 농후발효유, 식물성크림혼합분말 및 기타 설탕 등을 혼합하여 건조시킨 분말 형태인 것이 바람직하다. 상기 요구르트 혼합 분말이 12중량% 미만으로 첨가될 경우, 배변활동 촉진 효과를 기대하기 어렵고, 20중량%를 초과하여 첨가될 경우, 설사와 같은 대장의 과민 반응이 우려될 수 있으므로, 상기 기재된 범위 값에 따라서 적절히 첨가하는 것이 바람직하다.The yogurt mixture powder used in powdered foods for improving intestinal health is preferably in the form of a powder obtained by mixing concentrated fermented milk, vegetable cream mixture powder, and other sugars. When the yogurt mixture powder is added in an amount of less than 12% by weight, it is difficult to expect a bowel activity promoting effect, and when it is added in excess of 20% by weight, hypersensitivity reactions of the large intestine such as diarrhea may be concerned, the value in the range described above It is preferable to add it appropriately according to.
장 건강 개선용 분말식품에 이용되는 이소말트가 10중량% 미만으로 첨가될 경우, 유산균을 충분하게 활성화시킬 수 없고 배변 활동 증가 효과를 충분하게 얻을 수 없으며, 15중량%를 초과하여 첨가될 경우, 분말의 감미가 너무 달아, 상대적으로 다른 분말들의 본연의 맛을 느끼기 어려워 기호성이 저감되는 문제가 있다.When isomalt used in powdered foods for improving intestinal health is added in an amount less than 10% by weight, lactic acid bacteria cannot be sufficiently activated and the effect of increasing bowel activity cannot be sufficiently obtained, and when it is added in excess of 15% by weight, The sweetness of the powder is so sweet that it is relatively difficult to feel the original taste of other powders, so that palatability is reduced.
장 건강 개선용 분말식품에 이용되는 치커리뿌리추출물 분말은 수용성 식이섬유로서, 스폰지 처럼 수분을 흡수하고 점성의 겔의 형성작용을 하여 소화기관을 자극한다. 그 결과, 배변량이 증가하고, 변비를 해소시킬 수 있는 효과가 있다. 치커리뿌리추출물 분말이 5중량% 미만으로 첨가될 경우, 수분의 흡수가 높지 않아 배변활동 촉진 효과를 기대하기 어렵고, 15 중량%를 초과하여 첨가될 경우, 수분의 흡수가 과다하게 되어, 더부룩함 및 복부팽윤을 유발 할 수 있는 문제가 있다.Chicory root extract powder, which is used in powdered foods for improving intestinal health, is a water-soluble dietary fiber, absorbing moisture like a sponge and acting as a viscous gel to stimulate the digestive system. As a result, the amount of defecation increases, and there is an effect that can relieve constipation. If the chicory root extract powder is added in an amount of less than 5% by weight, it is difficult to expect the effect of promoting the bowel movement because the absorption of moisture is not high, and when it is added in excess of 15% by weight, the absorption of moisture becomes excessive, resulting in bloating and There is a problem that can cause abdominal swelling.
장 건강 개선용 분말식품에 이용되는 자일리톨은 청량감 및 감미를 증진시키기 위하여 사용되며, 5중량% 미만으로 첨가될 경우, 맛과 청량감이 저하되며, 10 중량%를 초과하여 첨가될 경우, 과량의 자일리톨로 인하여 칼로리가 높아질 수 있는 문제가 있다.Xylitol, which is used in powdered foods for improving intestinal health, is used to enhance the refreshing sensation and sweetness, and when it is added in less than 5% by weight, the taste and refreshing sensation decrease, and when it is added in excess of 10% by weight, an excessive amount of xylitol There is a problem that can increase calories due to.
장 건강 개선용 분말식품에 이용되는 유산균혼합분말은 장의 연동 운동을 촉진시키고, 장내 유해균의 증식을 억제하는 장정작용이 뛰어난 인체에 유익한 유산균이 사용된다. 유산균혼합분말이 3중량% 미만으로 첨가될 경우, 장 건강 개선에 대한 첨가 효과가 미약하고, 7중량% 초과을 초과하여 첨가될 경우, 장 건강 개선에 대한 첨가 상승효과가 미약하여 경제적이지 못하며, 장내의 다른 유효 세균들의 성장을 저해하는 단점이 있다.Lactobacillus mixed powder used in powdered foods for improving intestinal health promotes peristaltic movement of the intestine and uses lactic acid bacteria that are beneficial to the human body with excellent intestinal function to inhibit the proliferation of harmful bacteria in the intestine. If the lactic acid bacteria mixture powder is added in an amount of less than 3% by weight, the effect of addition to the improvement of intestinal health is weak, and if it is added in excess of 7% by weight, the synergistic effect of addition to the improvement of intestinal health is weak, which is not economical. There is a disadvantage of inhibiting the growth of other effective bacteria.
또한, 상기 유산균혼합분말은 유산균 56.4 중량% 및 전분가공품 43.6 중량%로 이루어진 것을 특징으로 한다.In addition, the lactic acid bacteria mixture powder is characterized by consisting of 56.4% by weight of lactic acid bacteria and 43.6% by weight of processed starch.
상기 유산균은 락토바실러스 플란타럼(Lactobacillus plantarum), 락토코커스 락티스 (Lactococcus lactis), 비피도박테리움 애니멀리스(Bifidobacterium animalis ssp. lactis), 락토바실러스 람노서스(Lactobacillus rhamnosus), 락토바실러스 카세이 (Lactobacillus casei), 비피도박테리움 브레베(Bifidobacterium breve), 비피도박테리움 롤검(Bifidobacterium longum), 락토바실러스 퍼멘텀(Lactobacillus fermentum) , 락토바실러스 루테리(Lactobacillus reuteri), 스트렙토코커스 써모필러스(Streptococcus thermophilus), 락토바실러스 에시도필러스(Lactobacillus acidophilus), 락토바실러스 파라카제이(Lactobacillus paracasei), 락토바실러스 불가리쿠스(Lactobacillus bulgaricus), 락토바실러스 가세리(Lactobacillus gasseri), 락토바실러스 헬베티커스(Lactobacillus helveticus) , 락토바실러스 살리바리우스(Lactobacillus salivarius), 비피도박테리움 비피덤(Bifidobacterium bifidum)으로 이루어진 것을 특징으로 하며, 상기 17종의 유산균이 장의 유해균 증식을 억제하고 장정작용을 촉진시킨다.The lactic acid bacteria are Lactobacillus plantarum, Lactococcus lactis, Bifidobacterium animalis ssp. lactis, Lactobacillus rhamnosus, Lactobacillus caser. casei), Bifidobacterium breve, Bifidobacterium longum, Lactobacillus fermentum, Lactobacillus reuteri, Streptococcus thermophilus (Streptococcus thermophilus) , Lactobacillus acidophilus, Lactobacillus paracasei, Lactobacillus bulgaricus, Lactobacillus gasseri, Lactobacillus gasseri, Lactobacillus helveticus, Lactobacillus helveticus It is characterized by consisting of Lactobacillus salivarius and Bifidobacterium bifidum, and the 17 kinds of lactic acid bacteria inhibit the proliferation of harmful bacteria in the intestine and promote bowel action.
장 건강 개선용 분말식품에 이용되는 프락토올리고당은 주원료가 원당인 물질로 칼로리가 적고 식이섬유가 풍부하여 장 건강에 도움을 주는 당류로서, 3중량% 미만으로 첨가될 경우, 맛의 증진, 장내 운동 촉진의 효과가 미약하고, 7중량% 초과을 초과하여 첨가될 경우, 장 건강 개선에 대한 첨가 상승효과가 미약하여 경제적이지 못하다.Fructooligosaccharide used in powdered foods for improving intestinal health is a substance whose main raw material is raw sugar. It is low in calories and rich in dietary fiber, so it is a saccharide that helps intestinal health. When added in less than 3% by weight, it enhances taste and intestines. The effect of promoting exercise is weak, and if it is added in excess of 7% by weight, the synergistic effect of addition for improving intestinal health is weak, and thus it is not economical.
장 건강 개선용 분말식품에 이용되는 요구르트향분말은 유산균 혼합 분말에 의한 특유의 신맛을 단맛으로 조화있게 하고, 분말의 이취를 저감시킨다. 요구르트향분말 2중량% 미만으로 첨가될 경우, 분말의 식미 내지 이취의 제거가 용이하지 못한 문제가 있고, 4중량%를 초과하여 첨가하는 경우에는 과일분말들이 특유의 풍미가 과잉의 요구르트향으로 인해 차폐되는 문제가 있다.The yogurt flavor powder used in powdered foods for improving intestinal health makes the unique acidity of the lactic acid bacteria mixed powder harmonize with sweet taste and reduces off-flavor of the powder. If the yogurt flavor powder is added in less than 2% by weight, there is a problem that it is difficult to remove the taste or off-flavor of the powder, and if it is added in excess of 4% by weight, the fruit powders have a characteristic flavor due to excessive yogurt aroma. There is a problem of being shielded.
장 건강 개선용 분말식품에 이용되는 이산화규소 및 스테아린산마그네슘은 장 건강 개선용 분말식품 조성물이 서로 균일하게 섞이게 하는 역할을 하므로, 0.5 중량% 미만으로 첨가될 경우, 여러 조성물이 균일하게 섞이지 않으며, 2 중량%를 초과하여 첨가하는 경우에는 과잉의 마그네슘과 이산화규소의 함량에 의하여 설사를 유발될 수 있는 문제가 있다.Silicon dioxide and magnesium stearate, which are used in powdered foods for improving intestinal health, play a role in uniformly mixing powdered food compositions for improving intestinal health, so when they are added in less than 0.5% by weight, various compositions are not uniformly mixed. If it is added in excess of weight %, there is a problem that diarrhea may be caused due to the excessive contents of magnesium and silicon dioxide.
장 건강 개선용 분말식품에 이용되는 동결건조딸기분말 및 사과농축분말은 Freeze-dried strawberry powder and apple concentrated powder used in powdered foods for improving intestinal health are
장 건강 개선용 분말식품에 이용되는 구연산 및 비타민C는 감미를 증진시키기 위하여 사용되며, 0.1 중량% 미만으로 첨가될 경우, 분말의 식미 내지 이취의 제거가 용이하지 못한 문제가 있고, 1중량%를 초과하여 첨가될 경우, 다른 성분들의 사용량이 상대적으로 감소하여, 본 발명에서 얻고자 하는 변비 내지 장 건강 개선의 목적을 완전히 달성할 수 없는 문제가 있다.Citric acid and vitamin C used in powdered foods for improving intestinal health are used to enhance sweetness, and when added in less than 0.1% by weight, there is a problem that it is not easy to remove the taste or off-flavor of the powder, and 1% by weight If it is added in excess, the amount of other ingredients is relatively reduced, so that the object of improving constipation or intestinal health to be obtained in the present invention cannot be completely achieved.
장 건강 개선용 분말식품에 이용되는 효소처리스테비아는 0.05 중량% 미만으로 첨가될 경우, 청량감과 단맛이 좋지 못해 기호도가 떨어지며, 0.5 중량%를 초과하여 첨가할 경우, 감미를 증진시키는 다른 성분들의 사용량이 상대적으로 감소하여, 오히려 종합적인 기호도가 저하되는 문제가 있다.Enzyme-treated stevia used in powdered foods for improving gut health, if added in less than 0.05% by weight, has poor refreshing sensation and sweetness, resulting in poor palatability, and when added in excess of 0.5% by weight, the use of other ingredients that enhance sweetness This relatively decreases, and there is a problem that the overall acceptability is rather deteriorated.
장 건강 개선용 분말식품에 이용되는 혼합야채분말은 0.05 중량% 미만으로 첨가될 경우, 본 발명의 목적인 장 건강 개선에 대한 첨가 효과가 미약하고, 0.1 중량%를 초과하여 첨가할 경우, 야채의 비린 맛이나 쓴 맛이 개선되지 않아, 감미가 저하될 수 있는 문제가 있다.When the mixed vegetable powder used in powdered foods for improving intestinal health is added in an amount of less than 0.05% by weight, the effect of addition for improving intestinal health, which is the object of the present invention, is weak, and when it is added in excess of 0.1% by weight, the fishiness of vegetables There is a problem in that the taste or bitter taste is not improved, and the sweetness may be lowered.
장 건강 개선용 분말식품 조성물은 얌빈 분말 0.5~1 중량%를 더 함유하여 제조될 수 있다. 얌빈 분말은 섬유질이 풍부하게 들어있어, 장내 유산균을 증식시킴으로써, 정장작용을 촉진할 수 있는 효과가 있다. 당업계에 알려진 통상적인 방법에 의해 건조된후 분쇄하여 제조될 수 있으며, 얌빈 분말이 0.5 중량% 미만으로 첨가될 경우, 첨가에 따른 변비 개선 및 장 건강 개선의 효과가 미약하며, 1 중량%를 초과하여 첨가할 경우, 식감 및 전체적인 맛이 저하되는 문제가 있다.The powdered food composition for improving intestinal health may be prepared by further containing 0.5 to 1% by weight of yambin powder. Yambin powder is rich in fiber, and by proliferating lactic acid bacteria in the intestine, it has the effect of promoting intestinal function. It can be prepared by pulverizing after drying by a conventional method known in the art, and when yambin powder is added in an amount of less than 0.5% by weight, the effect of improving constipation and intestinal health according to the addition is weak, and 1% by weight is When added in excess, there is a problem that the texture and overall taste are deteriorated.
이에 따라서, 장 건강 개선용 분말식품 조성물은 상기 기재된 범위 값에 따라서 적절히 첨가하는 것이 바람직하다.Accordingly, it is preferable to appropriately add the powdered food composition for improving intestinal health according to the above-described range value.
앞서 기재된 장 기능 활성이 증진된 혼합야채분말을 이용함으로써, 편식으로 인해 야채 섭취가 부족한 소비자들 특히, 어린이의 장 건강을 개선할 수 있는 효과를 가진다. 다시 말해, 정장 작용 및 배변촉진에 대한 효과가 있는 혼합야채분말 및 상기 혼합야채분말을 유효성분으로 함유하는 장 기능 개선용 분말식품을 제공할 수 있는 효과가 있다.By using the mixed vegetable powder with enhanced intestinal function activity described above, it has the effect of improving the intestinal health of consumers, especially children, who have insufficient vegetable intake due to unbalanced diet. In other words, there is an effect of providing a mixed vegetable powder having an effect on intestinal action and promoting bowel movement and a powdered food for improving intestinal function containing the mixed vegetable powder as an active ingredient.
또한, 장 건강 개선용 분말식품은 인체에 유해한 문제를 야기 시킬 수 있는 착색료 및 합성감미료 등을 첨가하지 않았으므로, 첨가제에 의한 2차 문제가 발생되지 않는다는 장점이 있다.In addition, since powdered foods for improving gut health are not added with coloring agents and synthetic sweeteners that may cause harmful problems to the human body, there is an advantage that secondary problems due to additives do not occur.
이하 실시예를 통하여 본 발명을 보다 상세하게 설명한다. 이들 실시예는 본 발명을 예시하는 것으로 본 발명의 범위가 이에 한정하지 않는다.The present invention will be described in more detail through the following examples. These examples are illustrative of the present invention and the scope of the present invention is not limited thereto.
1. 혼합 야채 분말의 제조1. Preparation of mixed vegetable powder
세척된 케일, 신선초, 연근, 시금치, 무 잎 및 삼백초를 30~50℃에서 8~15시간 동안 저온 건조한다. 이 후, 건조된 케일, 신선초, 연근, 시금치, 무 잎 및 삼백초를 각각 믹서로 분쇄하여 50~120 mesh의 케일 분말, 신선초 분말, 연근 분말, 시금치 분말, 무 잎 분말 및 삼백초 분말을 제조 하였다.Washed kale, fresh vinegar, lotus root, spinach, radish leaves and 300 vinegar are dried at low temperature for 8-15 hours at 30-50℃. Thereafter, the dried kale, fresh vinegar, lotus root, spinach, radish leaves, and 300 vinegar were pulverized with a mixer, respectively, to prepare 50-120 mesh kale powder, fresh vinegar powder, lotus root powder, spinach powder, radish leaf powder and tribac vinegar powder.
2. 혼합 야채 분말의 배합 (실시예1)2. Blending of mixed vegetable powder (Example 1)
■ 시험예1. ■ Test Example 1. 혼합야채분말의 장 운동을 촉진효과.The effect of promoting bowel movement of mixed vegetable powder.
1) 실험방법1) Experiment method
상기 혼합야채분말의 장 운동 촉진 효과를 측정하기 위하여, 6주령 수컷 랫트를 이용해 10일 동안 순화 후, 24시간 동안 절식시켰다. 이후, 실험물질 투여 1일전 측정한 분변 및 수분함량을 기준으로, 군당 8마리씩, 총 5개 군으로 선별하여 실험에 사용하였고, 하기의 표 2의 조건으로 실험을 진행하였다.In order to measure the intestinal motility promoting effect of the mixed vegetable powder, 6-week-old male rats were purified for 10 days and then fasted for 24 hours. Thereafter, based on the feces and water content measured 1 day before administration of the test substance, 8 animals per group, a total of 5 groups, were selected and used for the experiment, and the experiment was conducted under the conditions shown in Table 2 below.
혼합야채분말의 장 운동 촉진 효과를 측정하기 위한 실험 물질로서, 배변촉진제인 SP(sodium picosulfate, Crown Pharm. Co. Korea), 실시예1에서 제조된 혼합야채분말을 증류수에 현탁하여 경구 투여하였다.As an experimental substance for measuring the intestinal motility promoting effect of the mixed vegetable powder, SP (sodium picosulfate, Crown Pharm. Co. Korea), a bowel promoting agent, the mixed vegetable powder prepared in Example 1 was suspended in distilled water and administered orally.
대조군normal
Control
2) 실험결과2) Experiment result
2.1. 변의 개수2.1. Number of sides
상기 표2에서 각 실험군에 규정된 실험물질 투여 1일전, 투여 시작일로부터 5일 및 10일째의 24시간 동안 변의 개수(fecal pellet)를 구분하여 표 3에 기재하였다.In Table 2, the number of fecal pellets for 24 hours on the first day before administration of the test substance specified in each experimental group, and for 24 hours on the 5th and 10th day from the start of administration, are classified and shown in Table 3.
24시간1 day before administration of test substance
24 hours
24시간5th day of administration of test substance
24 hours
24시간10th day of administration of test substance
24 hours
2.2. 대장 내의 잔여 변의 개수2.2. The number of remaining stools in the large intestine
도 2는 실험 대상 랫트에 각 실험군에서 규정된 실험물질을 투여한 후 대장 내의 잔여 변의 개수 변화를 나타낸 그래프이다. 대장 내의 잔여 변의 개수(Remnant Fecal Pellets)는 각 실험군에 포함된 8 개체의 평균±표준편차(S.D.standard deviation)로 표시하였다.2 is a graph showing the change in the number of residual stools in the large intestine after administration of the experimental substances specified in each experimental group to the rats to be tested. The number of residual stools (Remnant Fecal Pellets) in the large intestine was expressed as the mean ± standard deviation of 8 individuals included in each experimental group.
실험예2의 결과, 혼합야채분말(실시예1)은 대장내의 잔여 변의 개수와 직경을 감소시킴으로써, 장 기능을 개선하는 것을 관찰 할 수 있었다.As a result of Experimental Example 2, it was observed that the mixed vegetable powder (Example 1) improved intestinal function by reducing the number and diameter of residual stools in the large intestine.
■ 시험예2. ■ Test Example 2. 장 건강 개선용 분말식품의 장 기능 개선 효과Effect of improving intestinal function of powdered foods for improving intestinal health
장 건강 개선용 분말식품은 하기의 표 4의 실시예2 및 실시예3과 같이 제조하였고, 상기 장 건강 개선용 분말식품에 이용되는 혼합야채분말은 실시예1에서 제조된 장 운동을 촉진하는 혼합야채분말을 이용하였다.Powdered foods for improving intestinal health were prepared as in Examples 2 and 3 of Table 4 below, and the mixed vegetable powder used in the powdered foods for improving intestinal health was mixed to promote bowel movement prepared in Example 1. Vegetable powder was used.
상기 실시예2 및 실시예3의 장 건강 개선용 분말식품의 장 운동 촉진 효과를 측정하기 위하여, 6 주령 수컷 랫트를 이용해 10일 동안 순화 후, 24시간 동안 절식시켰다. 이후, 실험물질 투여 1일전 측정한 분변 및 수분함량을 기준으로, 군당 8마리씩, 총 5개 군으로 선별하여 실험에 사용하였고, 하기의 표 5의 조건으로 실험을 진행하였다. In order to measure the intestinal motility promoting effect of the powdered foods for improving intestinal health of Examples 2 and 3, 6-week-old male rats were purified for 10 days and then fasted for 24 hours. Thereafter, based on the feces and water content measured 1 day before administration of the test substance, 8 animals per group, a total of 5 groups, were selected and used for the experiment, and the experiment was conducted under the conditions shown in Table 5 below.
장 건강 개선용 분말식품의 장 기능 활성 증진 효과를 측정하기 위한 실험 물질로서, 배변촉진제인 SP(sodium picosulfate, Crown Pharm. Co. Korea), 변비유발제인 LP(Loperamide hydrocholoride), 실시예2 및 실시예3 에서 제조된 분말을 증류수에 현탁하여 경구 투여하였다.As an experimental substance for measuring the effect of enhancing intestinal function activity of powdered foods for improving intestinal health, SP (sodium picosulfate, Crown Pharm. Co. Korea), which is a bowel promoting agent, LP (Loperamide hydrocholoride), which is an agent for constipation, Example 2 and implementation The powder prepared in Example 3 was suspended in distilled water and administered orally.
대조군normal
Control
-멸균 증류수-Physiological saline solution
-Sterile distilled water
-멸균증류수-Constipation inducing agent LP
-Sterile distilled water
-배변촉진제 SP-Constipation inducing agent LP
-Stool accelerator SP
-장 건강 개선용 분말300mg/kg-Constipation inducing agent LP
-Intestinal health improvement powder 300mg/kg
-장 건강 개선용 분말300mg/kg-Constipation inducing agent LP
-Intestinal health improvement powder 300mg/kg
분변지표를 비교함에 있어서, 하기의 표 6과 같이 측정하였다.In comparing the fecal index, it was measured as shown in Table 6 below.
2) 실험결과2) Experiment result
2.1 대장 내의 잔여 변의 개수2.1 Number of remaining stools in the large intestine
도 3를 참조하면, 변비유발제 대조군은 대장 내 잔여 변의 개수 및 평균 직경의 증가가 나타나지만, 배변촉진제 투여군, 실시예2 및 실시예3 투여군에서 정상 대조군에 비해 대장 내 잔여 변의 개수 및 평균 직경의 감소가 나타나는 것을 알 수 있다.3, the constipation-inducing agent control group showed an increase in the number and average diameter of residual stools in the large intestine, but the number and average diameter of the residual stools in the large intestine decreased compared to the normal control group in the bowel promoting agent administration group, Examples 2 and 3 You can see that appears.
2.2 변의 개수, 습중량, 건조중량 및 수분함량 비교2.2 Comparison of number of stools, wet weight, dry weight and moisture content
상기의 표6에 의하여, 측정한 변의개수, 습중량, 건조중량 및 수분함량은 하기의 표7에 기재하였다.According to Table 6 above, the measured number of sides, wet weight, dry weight, and moisture content are shown in Table 7 below.
24시간 동안1 day before administration of test substance
for 24
24시간 동안4 days after the end of administration of the test substance
for 24 hours
(g/rat)Wet weight
(g/rat)
(g/rat)Dry weight
(g/rat)
(%/rat)Moisture content
(%/rat)
(g/rat)Wet weight
(g/rat)
(g/rat)Dry weight
(g/rat)
(%/rat)Moisture content
(%/rat)
실험 결과에 의하면, 투여 시작 전 분변 개수, 습중량, 건조중량 및 수분함량 값은 모든 실험군에서 유사하였다. 그러나, 변비유발제 대조군에서 4일후 정상 대조군에 비해 유의성 있는 분변 개수 및 수분함량의 증가를 확인 할 수 있었으며, 배변촉진제 투여군에서도 변비유발제 대조군에 비해 유의성 있는 분변개수 및 수분함량의 증가가 확인되었다.According to the experimental results, the number of feces, wet weight, dry weight, and moisture content before the start of administration were similar in all experimental groups. However, after 4 days in the constipation-inducing agent control group, a significant increase in the number of feces and water content was confirmed compared to the normal control group, and in the constipation-inducing agent control group, a significant increase in the number of feces and water content was confirmed compared to the constipation inducing agent control group.
2.3 장내 분변 이동률 변화2.3 Changes in intestinal fecal migration rate
도 4을 참조하면, 변비유발제 대조군은 정상 대조군에 비해 유의성 있는 장내 분변 이동률의 감소를 나타내지만, 실시예2 및 실시예3투여군에서는 변비유발제 대조군에 비해 유의성 있는 용량 의존적인 장내 분변 이동율의의 증가가 나타났다. 또한, 배변촉진제 투여군 역시 변비유발제 대조군에 비해 유의성 있는 장내 분변이동율의 증가를 나타내었다.4, the constipation-inducing agent control group showed a significant decrease in the intestinal fecal migration rate compared to the normal control group, but the dose-dependent increase in the intestinal fecal migration rate in Examples 2 and 3 was significant compared to the constipation-inducing agent control group. Appeared. In addition, the bowel promoting agent administration group also showed a significant increase in the intestinal fecal migration rate compared to the constipation inducing agent control group.
상기와 같은 실험 결과에 따라서, 실시예2 및 실시예3의 장 건강 개선된 이유는 하기와 같은 이유로 유추할 수 있다.According to the above experimental results, the reason for the improvement in intestinal health of Examples 2 and 3 can be inferred for the following reasons.
첫째, 장 건강 개선용 분말식품 조성물에 함유된 비흡수성 당류가 소장에서 흡수되지 않고 대장을 통해 배설됨으로써, 대장연동운동의 조절작용과 조절작용을 통해 생리적 배변을 유도하기 때문인 것으로 유추할 수 있다.First, it can be inferred that this is because the non-absorbable saccharides contained in the powdered food composition for improving intestinal health are not absorbed in the small intestine and are excreted through the large intestine, thereby inducing physiological defecation through the control and control action of the colonic movement.
둘째, 유산균이 유산과 초산을 생산하여 장의 연동운동을 증가시켜 주는 것으로 유추할 수 있다.Second, it can be inferred that lactic acid bacteria produce lactic acid and acetic acid to increase intestinal peristalsis.
셋째, 장 건강 개선용 분말식품 조성물의 식이성분이 수분을 흡수하고 소화기관을 자극함으로써, 자율신경에 지배되는 장관의 긴장을 풀어주고, 배변량을 증가시키는 것으로 유추할 수 있다. 또한, 실시예 2가 실시예3보다 배변량이 증가된 요인은 식이섬유가 풍부한 얌빈 분말이 장 건강 개선용 분말식품 조성물에 포함되어 배변량을 증가시킨 것으로 유추할 수 있다.Third, it can be inferred that the dietary component of the powdered food composition for improving intestinal health absorbs moisture and stimulates the digestive system, thereby releasing the tension in the intestinal tract dominated by the autonomic nervous system and increasing the amount of defecation. In addition, it can be inferred that Example 2 increased the amount of bowel movements compared to Example 3 because yambin powder rich in dietary fiber was included in the powdered food composition for improving intestinal health to increase the amount of bowel movements.
이에 따라서, 본 발명은 장 기능 개선에 효과가 있는 장 건강 개선용 분말식품을 제공할 수 있는 효과가 있다.Accordingly, the present invention has the effect of providing a powdered food for improving intestinal health that is effective in improving intestinal function.
■ 시험예3 ■ Test Example 3 혼합야채분말을 포함하는 장 건강 개선용 분말식품의 기호성 평가Evaluation of palatability of powdered foods for improving intestinal health including mixed vegetable powder
1) 실험방법1) Experiment method
관능평가는 10대부터 50대에 해당하는 그 취지를 주지시킨 남녀 50명의 요원을 상대로 실시하였다. 평가 항목은, 향, 맛 및 종합적 기호도를 10점 척도법(10점: 매우 우수하다, 1점: 매우 나쁘다)에 따라 평가하였다.The sensory evaluation was conducted on 50 men and women who were in their teens to 50s. The evaluation items were evaluated according to a 10-point scale (10 points: very good, 1 point: very bad) for aroma, taste, and overall acceptability.
상기 실시예1로 제조된 혼합 야채분말과 혼합야채분말을 포함하는 장건강 개선용 분말식품인 실시예2 및 실시예3 관능성 평가를 실시하였다.Examples 2 and 3, which are powdered foods for improving intestinal health including the mixed vegetable powder and the mixed vegetable powder prepared in Example 1, were subjected to sensory evaluation.
2) 실험결과2) Experiment result
결과를 평균값과 표준편차로 하여 아래의 표8에 나타내었다.The results are shown in Table 8 below as the average value and the standard deviation.
상기 표 8에 나타낸 바와 같이, 본 발명의 기호도 조사 결과 실시예 1 내지 실시예 3 모두 비교적 기호도가 좋다고 인식될 수 있는 기호도 점수 5이상으로 확인되었다. 특히 실시예 2 및 실시예3은 기호도 점수 7이상으로서, 기호도가 매우 좋은 것으로 나타났다.As shown in Table 8 above, as a result of the preference survey of the present invention, the preference score that can be recognized as relatively good preference for all of Examples 1 to 3 was confirmed as a score of 5 or higher. Particularly, Example 2 and Example 3 had a preference score of 7 or higher, indicating very good preference.
상기와 같은 기호도 결과는 정제포도당, 요쿠르트 혼합분말, 자일리톨, 프락토올리고당, 동결건조딸기분말, 사과농축분말, 구연산 및 비타민C 와 같은 감미를 증진시킬 수 있는 물질을 배합비에 따라 혼합함으로써, 기호성을 증진시킨 것으로 유추할 수 있다. The above-described preference results are obtained by mixing substances that can enhance sweetness such as purified glucose, yogurt mixed powder, xylitol, fructooligosaccharide, freeze-dried strawberry powder, apple concentrated powder, citric acid, and vitamin C according to the mixing ratio. It can be inferred that it was enhanced.
Claims (8)
정제포도당 35.5 중량%, 요구르트 혼합 분말 16.7 중량%, 이소말트 12 중량%, 치커리뿌리추출물 분말 10 중량%, 자일리톨 7.8 중량% 유산균혼합분말 5 중량%, 프락토올리고당 5 중량%, 요구르트향분말 3 중량%, 이산화규소 1 중량%, 스테아린산마그네슘 1 중량%, 동결건조딸기분말 0.5 중량%, 사과농축분말 0.5 중량%, 구연산 0.5 중량%, 비타민C 0.5 중량%, 효소처리스테비아 0.2 중량%, 혼합야채분말 0.1 중량%, 얌빈분말 0.7 중량%를 유효성분으로 함유하되,
상기 혼합야채분말은 a) 세척된 케일, 신선초, 연근, 시금치, 무 잎 및 삼백초를 30~50℃에서 8~15시간 동안 저온 건조 하는 단계;
b) 건조된 케일, 신선초, 연근, 시금치, 무 잎 및 삼백초를 각각 믹서로 분쇄하여 50~120 mesh의 케일 분말, 신선초 분말, 연근 분말, 시금치 분말, 무 잎 분말 및 삼백초 분말을 제조하는 단계;
혼합야채분말의 총 중량을 기준으로 상기 케일 분말은 20~40 중량%, 상기 신선초 분말은 20~30 중량%, 상기 연근 분말은 10~20 중량%, 상기 시금치 분말은 10~20 중량%, 상기 무 잎 분말은 5~15 중량% 및 상기 삼백초 분말은 5~15 중량%를 혼합하는 단계;를 포함하여 제조된 것을 이용하는 것을 특징으로 하는 장 건강 개선용 분말식품 조성물.
In the powdered food composition for improving intestinal health,
Refined glucose 35.5% by weight, yogurt mixture powder 16.7% by weight, isomalt 12% by weight, chicory root extract powder 10% by weight, xylitol 7.8% by weight lactic acid bacteria mixture powder 5% by weight, fructooligosaccharide 5% by weight, yogurt flavor powder 3% by weight %, silicon dioxide 1% by weight, magnesium stearate 1% by weight, freeze-dried strawberry powder 0.5% by weight, apple concentrated powder 0.5% by weight, citric acid 0.5% by weight, vitamin C 0.5% by weight, enzyme-treated stevia 0.2% by weight, mixed vegetable powder It contains 0.1% by weight and 0.7% by weight of yambin powder as an active ingredient,
The mixed vegetable powder is a) step of drying the washed kale, fresh vinegar, lotus root, spinach, radish leaves and three hundred vinegar at 30-50 ℃ for 8-15 hours at low temperature;
b) pulverizing the dried kale, fresh vinegar, lotus root, spinach, radish leaves, and 300 vinegar with a mixer to prepare 50-120 mesh kale powder, fresh vinegar powder, lotus root powder, spinach powder, radish leaf powder and tribaekcho powder;
Based on the total weight of the mixed vegetable powder, the kale powder is 20 to 40% by weight, the fresh vinegar powder is 20 to 30% by weight, the lotus root powder is 10 to 20% by weight, the spinach powder is 10 to 20% by weight, the Powdered food composition for improving intestinal health, characterized in that using the prepared thing including; mixing the radish leaf powder 5-15% by weight and the tribaekcho powder 5-15% by weight.
상기 유산균혼합분말은 유산균 56.4 중량% 및 전분가공품 43.6 중량%로 이루어진 것을 특징으로 하는 장 건강 개선용 분말식품 조성물.The method of claim 1,
The lactic acid bacteria mixed powder is a powdered food composition for improving intestinal health, characterized in that consisting of 56.4% by weight of lactic acid bacteria and 43.6% by weight of processed starch.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020190038946A KR102226434B1 (en) | 2019-04-03 | 2019-04-03 | A mixed vegetable powder for promoting intestinal motility and a powdery food composition for improving intestinal health containing it as an active ingredient |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020190038946A KR102226434B1 (en) | 2019-04-03 | 2019-04-03 | A mixed vegetable powder for promoting intestinal motility and a powdery food composition for improving intestinal health containing it as an active ingredient |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20200117185A KR20200117185A (en) | 2020-10-14 |
| KR102226434B1 true KR102226434B1 (en) | 2021-03-11 |
Family
ID=72846920
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020190038946A KR102226434B1 (en) | 2019-04-03 | 2019-04-03 | A mixed vegetable powder for promoting intestinal motility and a powdery food composition for improving intestinal health containing it as an active ingredient |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR102226434B1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20230102580A (en) | 2021-12-30 | 2023-07-07 | 단국대학교 천안캠퍼스 산학협력단 | Preparing method for soymilk yogurt using Bacillus subtilis |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101450968B1 (en) * | 2012-11-22 | 2014-10-22 | 손귀자 | Constipation and other digestive health related food product and its manufacturing process |
| KR101539382B1 (en) * | 2015-05-14 | 2015-07-27 | 주식회사 웰솔루션 | Food composition for improvement of bowel function and relief of constipation |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100336648B1 (en) * | 2000-12-26 | 2002-05-16 | 강창환 | The composites of fermented vegetable drinks possessing the function of cleaning the bowels and relieving constipation |
| KR100486630B1 (en) | 2004-01-30 | 2005-05-03 | 오정해 | Functional dietary fiber supplement for the improvement of intestinal health and manufacturing method thereof |
| KR20150006970A (en) * | 2013-07-10 | 2015-01-20 | 주식회사 삼채 | A pharmaceutical composition for prevention or treatment of constipation comprising allium hookeri and pachyrhizus erosus as effective components and health functional food comprising the same |
| KR20160109109A (en) * | 2015-03-10 | 2016-09-21 | 염순봉 | Dried vegetables and natural seasoning mixture method using a drying vegetable mixture and the mixture dried vegetables according to a method of manufacturing the same |
| KR101597260B1 (en) | 2015-07-21 | 2016-02-24 | (주)웰팜 | Composite of powder youhurt and intake method |
| KR101909466B1 (en) | 2018-01-24 | 2018-10-18 | 조인바이 주식회사 | Vegetable powder food composition and the method for manufacturing the same |
-
2019
- 2019-04-03 KR KR1020190038946A patent/KR102226434B1/en active IP Right Grant
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101450968B1 (en) * | 2012-11-22 | 2014-10-22 | 손귀자 | Constipation and other digestive health related food product and its manufacturing process |
| KR101539382B1 (en) * | 2015-05-14 | 2015-07-27 | 주식회사 웰솔루션 | Food composition for improvement of bowel function and relief of constipation |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20230102580A (en) | 2021-12-30 | 2023-07-07 | 단국대학교 천안캠퍼스 산학협력단 | Preparing method for soymilk yogurt using Bacillus subtilis |
Also Published As
| Publication number | Publication date |
|---|---|
| KR20200117185A (en) | 2020-10-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4391971B2 (en) | Food composition having intestinal environment improving action | |
| CN111972670A (en) | Composition for relaxing bowel, solid beverage and application | |
| CN104855956A (en) | Medical formula food for insomnia | |
| KR101539382B1 (en) | Food composition for improvement of bowel function and relief of constipation | |
| CN102125105A (en) | New-prebiotics-added milk slice and preparation method thereof | |
| CN104489462B (en) | A kind of xylo-oligosaccharide probiotic powder | |
| CN106723087A (en) | A kind of tablet containing kelp dietary fiber and preparation method thereof | |
| US20060045924A1 (en) | Dried fruit composition with laxative effects and method for administration thereof | |
| KR20180084069A (en) | Food supplements and compositions for the treatment of metabolic syndrome | |
| US20200107569A1 (en) | Nutritional Composition of Blended Vegetarian Proteins | |
| KR100716123B1 (en) | Food composition comprising fermented dioscorea batatas decne. and the rhizoma thereof with lactic acid for preventing and improving constipation and obesity | |
| CN112931743A (en) | Solid beverage beneficial to body shaping and preparation method thereof | |
| CN114208989A (en) | Ketogenic meal replacement nutrition powder solid beverage and preparation method thereof | |
| KR102513975B1 (en) | Health functional food composition for improving intestinal health containing psyllium hull | |
| US20110144006A1 (en) | Protein composition | |
| CN104839662A (en) | Respiratory system disease medical formula food | |
| KR102226434B1 (en) | A mixed vegetable powder for promoting intestinal motility and a powdery food composition for improving intestinal health containing it as an active ingredient | |
| KR102240818B1 (en) | Tricolor sundae with increased digestion and palatability and manufacturing method thereof | |
| CN112617083A (en) | Prebiotics solid beverage capable of relaxing bowel and reducing blood sugar and preparation method thereof | |
| KR102102564B1 (en) | Constipation improving composition and health food prepared therefrom | |
| KR102000170B1 (en) | Food compositions for reducing body fat and improving intestinal function | |
| CN108618140A (en) | The antenatal conditioning medicine formula food of pregnant woman | |
| KR20040037011A (en) | Food Composition Containing a Lactic Acid Bacteria | |
| KR101421284B1 (en) | Composition for Improving Constipation and Manufacturing Method thereof | |
| JP2006182654A (en) | Body fat accumulation suppressing or reducing agent |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| E701 | Decision to grant or registration of patent right |